TrialESMO open2022

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

M P Saunders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.